Discovery and identification of anti-U1-A snRNP antibody in lung cancer

Science in China, Series C: Life Sciences

Volumn 48, Issue 6, 2005, Pages 641-647

  Zhang, Lijuan ^a   Liu, Jifu ^b   Zhang, Hao ^a   Wu, Shanshan ^b   Huang, Lingyun ^a   He, Dacheng ^a   Xiao, Xueyuan ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Autoantibody; Lung cancer; U1 A snRNP

Indexed keywords

AUTOANTIBODY; CANCER ANTIBODY; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; U1A PROTEIN;

ADENOCARCINOMA; ARTICLE; BLOOD; CASE CONTROL STUDY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG TUMOR; MALE; MASS SPECTROMETRY; METHODOLOGY; PREVALENCE; PROGNOSIS; PROTEIN MICROARRAY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIBODIES, NEOPLASM; AUTOANTIBODIES; BLOTTING, WESTERN; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUNG NEOPLASMS; MALE; NUCLEAR PROTEINS; PREVALENCE; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; RNA-BINDING PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33746404842     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1360/062005-82     Document Type: Article

References (11)

1. Soussi, T., p53 antibodies in the sera of patients with various types of cancer: A review, Cancer Res., 2000, 60: 1777-1788.
2. Tomkiel, J. E., Alansari, H., Tang, N. et al., Autoimmunity to the Mr. 32000 subunit of replication protein A in breast cancer, Clin. Cancer Res., 2002, 8: 752-758.
3. Felix, F. M., Pamela, J., Vande, V. et al., Antinuclear antibodies as potential markers of lung cancer. Clin. Cancer Res., 1999, 5: 1393-1400.
4. Zeng, C., He, D., Berget, S. M. et al., Nuclear-Mitotic apparatus protein: Structural protein interface between the nucleoskeleton and RNA splicing, Proc. Natl. Acad. Sci. USA, 1994, 91: 1505-1509.
5. Xiao, X. Y., Liu, D. H., Tang, Y. et al., Development of proteomic patterns for detecting lung cancer, Dis. Markers, 2003, 19(1): 33-39.
6. Chen, P., Xie, J. Y., Liang, S. P., Identification of protein spots in sliver-stained two-dimensional gels by MALDI-TOF mass peptide map analysis, Acta Biochim. Biophys. Sin., 2000, 32: 387-391.
7. Adam, B. L., Qu, Y., Davis, J. W. et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men, Cancer Res., 2002, 62: 3609-3614.
8. Petricoin, III E. F., Ardekani, A. M., Hitt, B. A. et al., Use of proteomic patterns in serum to identify ovarian cancer, The Lancet, 2002, 359: 572-577.
9. Xiao, X. Y., Zhao, X., Liu, J. K. et al., Discovery of laryngeal carcinoma by serum proteomic pattern analysis, Sci. China, 2004, 47(3): 219-223.
10. Félix, F. M., Pamela, J., Vande, V. et al., Antinuclear antibodies as potential markers of lung cancer, Clin. Cancer Res., 1999, 5: 1393-1400.
11. Kubo, M., Ihn, H., Kuwana, M. et al., Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap, Rhrumatology, 2002, 41: 531-534.